Adeia Named a Top 100 Global Innovator for 2026 by LexisNexis
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
Aduro Signs MOU to Develop a Commercial Licence Package for Hydrochemolytic™ Technology